Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes

NCT00698802 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: EX1000
DRUG: biphasic human insulin

Sponsor

Novo Nordisk A/S